A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls

Oncogenesis

Volumn 5, Issue , 2016, Pages

  Wu, Y ^a,b   Wang, Y Q ^b   Weng, W W ^a,b   Zhang, Q Y ^a,b   Yang, X Q ^a,b   Gan, H L ^a,b   Yang, Y S ^a,b   Zhang, P P ^a,b   Sun, M H ^a,b   Xu, M D ^a,b   Wang, C F ^c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; TUMOR MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM;

EID: 84959498613     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2015.48     Document Type: Article

References (43)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA 2014; 64: 9-29.
2. Wang C, Yu C, Yang F, Yang G. Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis. Tumour Biol 2014; 35: 6343-6350.
3. Olshan AF, Kuo TM, Meyer AM, Nielsen ME, Purdue MP, Rathmell WK. Racial difference in histologic subtype of renal cell carcinoma. Cancer Med 2013; 2: 744-749.
4. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009; 373: 1119-1132.
5. Brugarolas J. Molecular genetics of clear-cell renal cell carcinoma. J Clin Oncol 2014; 32: 1968-1976.
6. Chan KC, Lo YM. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers. Br J Cancer 2007; 96: 681-685.
7. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids-a promising, non-invasive tool for early detection of several human diseases. FEBS Lett 2007; 581: 795-799.
8. Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 2006; 24: 1754-1760.
9. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
10. Ferracin M, Lupini L, Salamon I, Saccenti E, Zanzi MV, Rocchi A et al. Absolute quantification of cell-free microRNAs in cancer patients. Oncotarget 2015; 6: 14545-14555.
11. Montani F, Marzi MJ, Dezi F, Dama E, Carletti RM, Bonizzi G et al. miR-Test: a blood test for lung cancer early detection. J Natl Cancer Inst 2015; 107: djv063.
12. Xu MD, Qi P, Du X. Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application. Mod Pathol 2014; 27: 1310-1320.
13. Dong L, Qi P, Xu MD, Ni SJ, Huang D, Xu QH et al. Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls. Int J Cancer 2015; 137: 1128-1135.
14. Xiang JF, Yin QF, Chen T, Zhang Y, Zhang XO, Wu Z et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res 2014; 24: 513-531.
15. Linehan WM. Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Res 2012; 22: 2089-2100.
16. Ashida S, Okuda H, Chikazawa M, Tanimura M, Sugita O, Yamamoto Y et al. Detection of circulating cancer cells with von Hippel-Lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin Cancer Res 2000; 6: 3817-3822.
17. Uemura H, Nakagawa Y, Iwai A, Okajima E, Okajima E, Yoshikawa K et al. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation. Aktuelle Urol 2003; 34: 270-272.
18. Zhao A, Li G, Peoc'h M, Genin C, Gigante M. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol 2013; 94: 115-120.
19. Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 2011; 6: e25787.
20. Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 2012; 10: 55.
21. Hirata H, Hinoda Y, Shahryari V, Deng GR, Nakajima K, Tabatabai ZL et al. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Res 2015; 75: 1322-1331.
22. Bertozzi D, Iurlaro R, Sordet O, Marinello J, Zaffaroni N, Capranico G. Characterization of novel antisense HIF-1 alpha transcripts in human cancers. Cell Cycle 2011; 10: 3189-3197.
23. Fachel AA, Tahira AC, Vilella-Arias SA, Maracaja-Coutinho V, Gimba ER, Vignal GM et al. Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations. Mol Cancer 2013; 12: 140.
24. Malouf GG, Zhang J, Yuan Y, Comperat E, Roupret M, Cussenot O et al. Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing. Mol Oncol 2015; 9: 32-43.
25. Blondeau JJ, Deng M, Syring I, Schrodter S, Schmidt D, Perner S et al. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma. Clin Epigenet 2015; 7: 10.
26. Ren SC, Wang FB, Shen J, Sun Y, Xu WD, Lu J et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer 2013; 49: 2949-2959.
27. Kogure T, Yan IK, Lin WL, Patel T. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer 2013; 4: 261-272.
28. Hasselmann DO, Rappl G, Tilgen W, Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem 2001; 47: 1488-1489.
29. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200: 373-383.
30. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of MicroRNAs in living cells. J Biol Chem 2010; 285: 17442-17452.
31. Ma MZ, Kong X, Weng MZ, Zhang MD, Qin YY, Gong W et al. Long non-coding RNA-LET is a positive prognostic factor and exhibits tumor-suppressive activity in gallbladder cancer. Mol Carcinog 2014; 54: 1397-1406.
32. He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett 2014; 344: 20-27.
33. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013; 49: 1083-1096.
34. Ruktanonchai CW, Pindolia DK, Striley CW, Odedina FT, Cottler LB. Utilizing spatial statistics to identify cancer hot spots: a surveillance strategy to inform community-engaged outreach efforts. Int J Health Geographics 2014; 13: 39.
35. Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 2014; 110: 164-171.
36. Zhang XW, Bu P, Liu L, Zhang XZ, Li J. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. Bioch Biophy Res Commun 2015; 462: 227-232.
37. Plotkin M, Besana GV, Yuma S, Kim YM, Kulindwa Y, Kabole F et al. Integrating HIV testing into cervical cancer screening in Tanzania: an analysis of routine service delivery statistics. BMC Women's Health 2014; 14: 120.
38. Waldon J, Lamb DS, Delahunt B, Nacey JN, Dady PJ, Johnson CA et al. A comparison of cancer statistics in New Zealand and Australia: 1996-2007. N Z Med J 2014; 127: 20-29.
39. Iwamoto M, Nakamura F, Higashi T. Estimated life expectancy and risk of death from cancer by quartiles in the older Japanese population: 2010 vital statistics. Cancer Epidemiol 2014; 38: 511-514.
40. Wang L, Han S, Jin G, Zhou X, Li M, Ying X et al. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgendependence to androgen-independence. Int J Oncol 2014; 44: 2041-2049.
41. Poliseno L, Salmena L, Zhang JW, Carver B, Haveman WJ, Pandolfi PP. A codingindependent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465: 1033-U90.
42. Batagov AO, Kuznetsov VA, Kurochkin IV. Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics 2011; 12: S18.
43. Irion U, St Johnston D. Bicoid RNA localization requires specific binding of an endosomal sorting complex. Nature 2007; 445: 554-558.